Cite
PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer.
MLA
Sutera, Philip, et al. “PIK3/Akt/MTOR Pathway Alterations in Metastatic Castration-Sensitive Prostate Cancer.” The Prostate, vol. 84, no. 14, Oct. 2024, pp. 1301–08. EBSCOhost, https://doi.org/10.1002/pros.24765.
APA
Sutera, P., Kim, J., Kumar, R., Deek, R. A., Stephenson, R., Mayer, T., Saraiya, B., Ghodoussipour, S., Jang, T., Golombos, D., Packiam, V., Ennis, R., Hathout, L., Jabbour, S. K., Guler, O., Onal, C., Tran, P. T., & Deek, M. P. (2024). PIK3/Akt/mTOR pathway alterations in metastatic castration-sensitive prostate cancer. The Prostate, 84(14), 1301–1308. https://doi.org/10.1002/pros.24765
Chicago
Sutera, Philip, Jongmyung Kim, Ritesh Kumar, Rebecca A Deek, Ryan Stephenson, Tina Mayer, Biren Saraiya, et al. 2024. “PIK3/Akt/MTOR Pathway Alterations in Metastatic Castration-Sensitive Prostate Cancer.” The Prostate 84 (14): 1301–8. doi:10.1002/pros.24765.